Journals / Turkish Journal of Surgery / 2017 / Cilt: 33 - Sayı: 2

The outcomes of intestinal resection during debulking surgery for ovarian cancer

Pages
96–99
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite the limited number of patients, the results obtained from the present study are comparable with previous reports.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the clinical and surgical outcomes of intestinal resection during primary debulking surgeryfor ovarian cancer.Material and Methods: This retrospective study was conducted at Zekai Tahir Burak Women's Health Training andResearch Hospital between 2009 and 2013.
📊
Key Findings & Data:The patients who underwent intestinal resection during debulking surgery for stage 3 ovarian cancer were included in the analysis.
💡
Conclusion & Impact:Despite the limited number of patients, the results obtained from the present study are comparable with previous reports.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To evaluate the clinical and surgical outcomes of intestinal resection during primary debulking surgeryfor ovarian cancer.Material and Methods: This retrospective study was conducted at Zekai Tahir Burak Women's Health Training andResearch Hospital between 2009 and 2013. The patients who underwent intestinal resection during debulking surgery for stage 3 ovarian cancer were included in the analysis. Data regarding patient age, body mass index, tumorhistology, disease stage, the site of intestinal resection, all postoperative complications, duration of intensive careunit admission and hospital stay were collected and analyzed.Results: A total of 22 patients with a mean age of 53.4 years were included in the study. Optimal cytoreduction wasachieved in 14 (63%) patients. Transverse colectomy was the most common type of intestinal resection (63%). Themost common postoperative complication was transfusion of blood products (63%). No postoperative mortality wasobserved.Conclusion: Intestinal resection is a crucial part of debulking surgery for advanced ovarian cancer, with acceptablecomplication rates. Despite the limited number of patients, the results obtained from the present study are comparable with previous reports.

🔖

Cite This Article

TERZİOĞLU, G. S., KILIÇ, M. Ö., ÇETİNKAYA, N., BAŞER, E., GÜNGÖR, T., ADIGÜZEL, C. (2017). The outcomes of intestinal resection during debulking surgery for ovarian cancer. Turkish Journal of Surgery, Cilt: 33 - Sayı: 2, 96–99. https://ajindex.com/articles/390510

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011
  2. [CrossRef] Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian can- cer. Lancet 2014
  3. [CrossRef] Hankinson SE, Danforth KN. Ovarian Cancer. Schottenfeld D, Fraumeni J. Cancer epidemiology and prevention. 3rd edn. New York, NY: Oxford University Press. 2006: 1013-1026. [CrossRef] Crandon AJ, Obermair A. Advanced cytoreductive surgery: Asia Pacific perspective. Gynecol Oncol 2009
  4. [CrossRef] Ghaemmaghami F, Hassanzadeh M, Karimi-Zarchi M, Modari- Gilani M, Behtash A, Mousavi N. Centralization of ovarian cancer surgery: do patients benefit? Eur J Gynaecol Oncol 2010
  5. Venesmaa P, Ylikorkala O. Morbidity and mortality associated with primary and repeat operations for ovarian cancer. Obstet Gynecol 1992
  6. [CrossRef] Castaldo TW, Petrilli ES, Ballon SC, Lagasse LD. Intestinal opera- tions in patients with ovarian carcinoma. Am J Obstet Gynecol 1981
  7. [CrossRef] Takahashi O, Tanaka T. Intestinal surgery in advanced ovarian cancer. Curr Opin Obstet Gynecol 2007
  8. [CrossRef] Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Per- rin LC, et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001
  9. [CrossRef] Hoskins WY, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994
  10. [CrossRef] Stuart GC, Kitchener H, Bacon M, duBois A, Friedlander M, Leder- mann J, et al. 2010 Gynecologic Cancer InterGroup (GCIG) con- sensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer 2011
  11. [CrossRef] Randall TC, Rubin SC. Cytoreductive surgery for ovarian cancer. Surg Clin North Am 2001
  12. [CrossRef] Hoskins WJ. Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 1994
  13. [CrossRef] du Bois A Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfis- terer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analy